SIMO [Silicon Motion Technology] 6-K: (Original Filing)

[Silicon Motion Announces Results for the Period Ended June 30, 2011 Second Quarter 2011 Financial Highlights • Net sales increased 16% quarter-over-quarter to US$50.5 million from US$43.4 million in 1Q11 • Gross margin excluding stock-based compensation increased to 46.9% from 46.2% in 1Q11 • Operating expenses excluding stock-based compensation, acquisition-related charges, and other items decreased to US$13.1 million from US$13.4] [Press Release issued by the Company on July 28, 2011.]

By | 2016-03-14T19:49:01+00:00 August 1st, 2011|Categories: Chinese Stocks, SEC Original, SIMO|Tags: , , , , , |0 Comments

SFUN [SouFun] 6-K: (Original Filing)

[SouFun Declares Cash Dividends to Shareholders BEIJING, August 1, 2011 — SouFun Holdings Limited (NYSE: SFUN, “SouFun”), the leading real estate and home furnishing Internet portal in China, today announced that its Board of Directors has approved and declared a cash dividend of US$1.00 per share on SouFun’s ordinary shares. Each of the SouFun’s American depositary shares (“ADS”) represents one]

VIMC [Vimicro International] 6-K: (Original Filing)

[First Quarter 2011 Results First Quarter 2011 Results Net revenue in the first quarter of 2011 was $13.0 million, compared to $18.9 million in the first quarter of 2010 and $24.4 million in the fourth quarter of 2010. (Figures from prior periods have been restated to account for discontinued operations following the divestiture of non-core IC businesses in December 2010.)]

By | 2016-03-31T19:29:17+00:00 August 1st, 2011|Categories: Chinese Stocks, SEC Original, VIMC|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] 8-K: (Original Filing)

[China Biologic’s 2 Plasma Collection Stations in Guizhou Province Have Been Inspected and Relicensed, 4 Other Stations in Disallowed Counties Closed on August 1, 2011 TAI’AN, China, August 1, 2011 /PRNewswire-Asia-FirstCall/ – China Biologic Products, Inc. (NASDAQ: CBPO) (“China Biologic,” or the “Company”), a leading plasma-based biopharmaceutical company in China, today announced that 2 of its plasma collection stations, in] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): August 1, 2011 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai'an City, Shandong, 271000 People's Republic of China 86-538 -620-2306 ____________________________________________________________ (Former name or former address, if changed]

EGT [Entertainment Gaming Asia] EFFECT: (Original Filing)

[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif} .FormText {font-size: x-small; font-family: arial, helvetica, sans-serif} .SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif} .FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold} .FormName {font-size: large; font-family: arial, helvetica, sans-serif;]

GURE [GULF RESOURCES] CORRESP: (Original Filing)

[Gulf Resources, Inc. 99 Wengchang Road, Chenming Industrial Park, Shouguang City, Shandong, China 262714 July 29, 2011 Terence O’Brien Accounting Branch Chief Division of Corporation Finance 100 F Street, N.E. Re: Gulf Resources, Inc. Dear Mr. O’Brien: Form 10-K for the Fiscal Year Ended December 31, 2010 Item 1. Business, page 1 Our Corporate History, page 1 1. We note]

By | 2016-03-18T07:18:32+00:00 July 29th, 2011|Categories: Chinese Stocks, GURE, SEC Original|Tags: , , , , , |0 Comments

KNDI [Kandi Technologies] 10-Q/A: (Original Filing)

[(86 - 0579) 82239856 þ ¨ Yes ¨ ¨ Yes ¨ Large accelerated filer ¨ Accelerated filer ¨ Non-accelerated filer þ Smaller reporting company ¨ þ Yes TABLE OF CONTENTS Page Explanatory Note 3 PART I— FINANCIAL INFORMATION Item 1. Condensed Consolidated Financial Statements 4 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 34 Item] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Hu Xiaoming, certify that: 1. I have reviewed this report on Form 10-Q/A of Kandi Technologies, Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Zhu Xiaoying, certify that: 1. I have reviewed this report on Form 10-Q/A of Kandi Technologies, Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [18 U.S.C. § 1350, § 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Hu Xiaoming President and Chief Executive Officer Zhu Xiaoying Chief Financial Officer July 29, 2011 EX-32.1 4 v229866_ex32-1.htm]

KNDI [Kandi Technologies] 10-K/A: (Original Filing)

[TABLE OF CONTENTS Explanatory Note 1 PART I Item 1. Business. 2- Item 1A. Risk Factors. 6-14] [I, Hu Xiaoming, certify that: I have reviewed this Amendment No. 1 to our annual report on Form 10-K/A of Kandi Technologies, Corp. 1. 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [I, Zhu Xiaoying, certify that: 1. I have reviewed this Amendment No. 1 to our annual report on Form 10-K/A of Kandi Technologies, Corp 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Hu Xiaoming President and Chief Executive Officer Zhu Xiaoying Chief Financial Officer July 29, 2011]

Skip to toolbar